BioSyent Inc.
RX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.43M | 1.95M | 1.46M | 1.62M | 1.15M |
| Total Depreciation and Amortization | 159.00K | 184.40K | 109.20K | 143.90K | 140.80K |
| Total Amortization of Deferred Charges | 3.40K | -37.60K | 44.50K | 3.20K | 28.00K |
| Total Other Non-Cash Items | 77.50K | -38.10K | -19.50K | 15.70K | 212.80K |
| Change in Net Operating Assets | 832.90K | -45.80K | 915.90K | -2.28M | 335.90K |
| Cash from Operations | 2.50M | 2.01M | 2.51M | -500.60K | 1.87M |
| Capital Expenditure | -9.80K | 9.20K | -13.50K | -13.90K | -6.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.72M | 318.10K | 137.60K | 766.60K | 636.90K |
| Cash from Investing | 1.71M | 327.40K | 124.10K | 752.70K | 630.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -51.80K | -49.40K | -48.00K | -47.50K | -46.60K |
| Issuance of Common Stock | 0.00 | 34.40K | 6.30K | 58.50K | 162.20K |
| Repurchase of Common Stock | -12.40K | -16.80K | -23.50K | -955.60K | -3.79M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -403.90K | -408.80K | -406.70K | -392.50K | -366.40K |
| Other Financing Activities | -11.50K | -12.10K | -12.60K | -13.10K | -14.00K |
| Cash from Financing | -458.20K | -440.70K | -463.00K | -1.06M | -3.00M |
| Foreign Exchange rate Adjustments | -8.90K | 5.10K | -5.00K | -500.00 | 22.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.75M | 1.90M | 2.16M | -808.10K | -477.20K |